This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Alliance For Lupus NYC Walk With Us To Cure Lupus First Lupus Walk In History To Raise $1-Million

$1 Million for Lupus Research

NEW YORK, Oct. 27, 2011 /PRNewswire-USNewswire/ -- A milestone in lupus research was met this weekend!  On Saturday, October 22 nd the Alliance for Lupus Research (ALR) held its 8th annual New York City Walk with Us to Cure Lupus.  The beautiful weather at Battery Park was matched by the enthusiasm of the nearly 3000 walkers in attendance to walk for the cure.  The walkers were joined by NYC master of ceremonies, My9 news anchor Brenda Blackmon, ALR Chairman Robert Wood Johnson IV, and Walk Co-chairs Frank Bisignano, Chief Administrative Officer JPMorgan Chase; Daniel LaVecchia, Executive Managing Director BGC Partners; and Mark Wagar, President & CEO Empire BlueCross BlueShield.  Spoken poet Shanelle Gabriel inspired the crowd with "Vanity", her moving personal account of life with lupus. 

The ALR NYC Walk with Us to Cure Lupus is the first lupus Walk in history to raise $1 million!  That's $1 million to fund research supporting the ALR's mission of finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus).   Not only did the ALR surpass the Walk's initial goal of $900,000; we made history.  The Walk provided a wonderful opportunity to give a voice to people affected by lupus.  We thank everyone for their support and unwavering commitment.

The Walk was supported by corporate sponsors Johnson & Johnson, Cantor Fitzgerald, BGC Partners, JPMorgan Chase, Empire BlueCross BlueShield, New York Yankees, New York Mets, Trump Organization, KPF Associates, Bank of America/Merrill Lynch, Human Genome Sciences, Pfizer, Montefiore The University Hospital for Albert Einstein College of Medicine, Bank of New York Mellon, KPMG, Verizon, Kraft Foods, CBS Sports, and Turner Construction Company.

About LupusSystemic lupus erythematosus (SLE, or lupus) is a chronic autoimmune disease that can affect the joints and almost every major organ in the body, including the heart, kidneys, skin, lungs, and brain.  As many as 1.5 million people in the United States have lupus which affects mostly women during childbearing years, though men and children can have the disease.  Lupus is three times more common in African-American women than in Caucasian women and is also more prevalent in women of Latino, Asian, and Native American descent. About the ALRThe Alliance for Lupus Research (ALR) is a national voluntary health organization dedicated to finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus), a debilitating autoimmune disease.  The organization is based in New York City and chaired by Robert Wood Johnson IV, a member of the founding family of Johnson & Johnson.  Since its founding in 1999, the ALR has given more money to lupus research than any non-governmental agency in the world.  The board of directors funds all administrative and fundraising costs, allowing one hundred percent of all donations from the public, and the proceeds of our signature grassroots fundraising program, Walk with Us to Cure Lupus, go directly to support research programs.  The organization has awarded more than $6 million in grants this year and, since 1999, has dedicated over $67 million to understanding the disease. More information can be found at www.lupusresearch.org.

SOURCE Alliance for Lupus Research

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs